Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Introducing new technologies into the clinic.

Srinivasan Vijayakumar1, Samir Narayan, Claus Chunli Yang

  • 1Department of Radiation Oncology, University of California, Davis Cancer Center, Sacramento, Calif. , USA.

Frontiers of Radiation Therapy and Oncology
|July 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiobiotherapy in Osteosarcoma: A State-Based Educational Framework for Strategy Selection and Trial Design.

Current oncology (Toronto, Ont.)·2026
Same author

Comparative Distribution of High-Risk Human Papillomavirus (HPV) Genotypes in India vs World Health Organization Regions and Countries: Implications for HPV Vaccination.

Ochsner journal·2026
Same author

Results From the Practice Accreditation Resident Reviewer Program (PARRP) Pilot: Educating Radiation Oncology Residents About Practice Accreditation.

Cureus·2026
Same author

The Association of p27 With Prostate Cancer Outcomes: A Secondary Analysis of NRG/RTOG 8610 and 9202.

Advances in radiation oncology·2026
Same author

Chemo-Nonresponsive Telangiectatic Osteosarcoma With Oligometastatic Recurrence Managed With Multimodality Therapy Including Stereotactic Ablative Body Radiotherapy (SABR): A Case Report With a Pathologic Treatment Effect.

Cureus·2026
Same author

Colorectal Cancer in Mississippi: How to Change the Tide of Bad News to a Success Story?

Cureus·2026

Comparing radiation oncology technologies requires evaluating dose distributions. Benchmark dose-volume histograms (DVHs) offer an intuitive method for comparing new and standard treatment plans, aiding clinical adoption.

Area of Science:

  • Radiation Oncology
  • Medical Physics
  • Clinical Technology Assessment

Background:

  • Implementing new radiation oncology technologies presents challenges in evaluating treatment efficacy.
  • Quantifying improvements in dose distribution compared to standard techniques is crucial for clinical practice.
  • Objective methods are needed to compare dosimetric outcomes of novel technologies.

Purpose of the Study:

  • To propose a conceptual model for comparing dose distributions of new radiation oncology technologies against established standards.
  • To introduce the benchmark dose-volume histogram (DVH) as a tool for evaluating dosimetric improvements.
  • To demonstrate the application of this method in prostate cancer treatment planning.

Main Methods:

  • Utilizing benchmark dose-volume histograms (DVHs) as a standard for comparison.

Related Experiment Videos

  • Calculating and comparing the area under the curve (AUC) of DVHs for new and standard techniques.
  • Applying the methodology to a prostate cancer case study.

    • Main Results:

    • Benchmark DVHs provide a global comparison of dose distributions.
    • The area under the curve comparison is intuitive, efficient, and easily implemented.
    • The proposed method facilitates the assessment of dosimetric superiority of new technologies.

    Conclusions:

    • Benchmark DVHs offer a practical framework for evaluating new technologies in radiation oncology.
    • This approach supports informed clinical decision-making regarding technology adoption.
    • The method has broad applicability across various disease sites and advanced treatment modalities beyond intensity-modulated radiation therapy.